OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
Published in:
Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. e401, doi. 10.1016/j.clgc.2021.08.007
By:
- Wilson, Nathaniel R.;
- Wiele, Andrew J.;
- Surasi, Devaki Shilpa;
- Rao, Priya;
- Sircar, Kanishka;
- Tamboli, Pheroze;
- Shah, Amishi Y.;
- Genovese, Giannicola;
- Karam, Jose A.;
- Wood, Christopher G.;
- Tannir, Nizar M.;
- Msaouel, Pavlos
Publication type:
Article
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.
Published in:
Cancers, 2021, v. 13, n. 9, p. 2170, doi. 10.3390/cancers13092170
By:
- Wiele, Andrew J.;
- Surasi, Devaki Shilpa;
- Rao, Priya;
- Sircar, Kanishka;
- Su, Xiaoping;
- Bathala, Tharakeswara K.;
- Shah, Amishi Y.;
- Jonasch, Eric;
- Cataldo, Vince D.;
- Genovese, Giannicola;
- Karam, Jose A.;
- Wood, Christopher G.;
- Tannir, Nizar M.;
- Msaouel, Pavlos;
- Wong, David
Publication type:
Article
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Published in:
Oncologist, 2024, v. 29, n. 5, p. 392, doi. 10.1093/oncolo/oyad302
By:
- Hahn, Andrew W;
- Surasi, Devaki Shilpa;
- Viscuse, Paul V;
- Bathala, Tharakeswara K;
- Wiele, Andrew J;
- Campbell, Matthew T;
- Zurita, Amado J;
- Shah, Amishi Y;
- Jonasch, Eric;
- Gao, Jianjun;
- Goswami, Sangeeta;
- Alhalabi, Omar;
- Rao, Priya;
- Sircar, Kanishka;
- Tannir, Nizar M;
- Msaouel, Pavlos
Publication type:
Article
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor‐Tyrosine Kinase Inhibitor Therapies.
Published in:
Oncologist, 2021, v. 26, n. 6, p. 476, doi. 10.1002/onco.13770
By:
- Wiele, Andrew J.;
- Bathala, Tharakeswara K.;
- Hahn, Andrew W.;
- Xiao, Lianchun;
- Duran, Munevver;
- Ross, Jeremy A.;
- Jonasch, Eric;
- Shah, Amishi Y.;
- Campbell, Matthew T.;
- Msaouel, Pavlos;
- Tannir, Nizar M.
Publication type:
Article

Found: 4

Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.

Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.

Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.

Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor‐Tyrosine Kinase Inhibitor Therapies.